Ninds drug manufacturing and formulation program (dmfp)
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N98026D00015
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Drug Manufacturing and Formulation Program (DMFP) Pre-Solicitation · 75N95024R00077 · Posted May 3, 2024
- Last date to order 5% complete
- IDV ceiling
- $49,999,999.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 7 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Neurological Disorders and Stroke awarded a multiple-award Indefinite Delivery Contract to Sri International on May 4, 2026, with a ceiling of $49,999,999 for the Drug Manufacturing and Formulation Program (DMFP), a component of the Blueprint Neurotherapeutics Network.
The IDIQ carries no set-aside and extends through May 3, 2036. Place of performance is not specified in the source. The contract supports API scale-up and manufacturing, formulation and dosage form manufacturing, analytical methods development, and stability testing for candidate molecules advancing toward clinical-stage development. Task orders will be issued for each DMFP project; the contract includes a Determination of Exceptional Circumstances enabling contributors to retain intellectual property control for investigational agents evaluated through the program.
The originating solicitation, posted May 3, 2024, anticipated multiple awards under a ten-year ordering period and sought offerors capable of executing API manufacturing, formulation development, analytical method development, and stability testing across the neurotherapeutic candidate pipeline. Full and open competition applied; the anticipated award date stated in the pre-solicitation (January 2025) was superseded by the actual May 4, 2026 award date.
Sri International is a non-profit research and development organization headquartered in Menlo Park, California, competing as a prime contractor on the vast majority of its federal portfolio and delivering advanced scientific and technical services across defense, civilian health research, energy, and education domains.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N98026D00015?
75N98026D00015 was awarded to Sri International by Office of Logisitics and Acquisition Operations (National Institutes of Health) on May 4, 2026.
How much is contract 75N98026D00015 worth?
75N98026D00015's own ceiling is $49,999,999.
Which agency awarded contract 75N98026D00015?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026D00015, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Who can order from contract 75N98026D00015?
75N98026D00015 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N98026D00015 competed?
The extent of competition for 75N98026D00015 was full and open competition. The government received 7 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV